Testosterone therapy in men with cirrhosis and low serum testosterone safely increases muscle mass, bone mass and hemoglobin, and reduces fat mass and HbA1c, reports November's publication of the Journal of Hepatology.
A study in the most recent issue of Hepatology identififes proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment, reports the latest issue of the European Journal of Gastroenterology & Hepatology.
A study in the latest issue of the Alimentary Pharmacology & Therapeutics validates the Leuven Postprandial Distress Scale, a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome.
Controlled dietary restriction with a prepackaged low-residue diet before colonoscopy offers better-quality bowel cleansing and allows the use of a smaller volume of purgatives, reports the most recent issue of the Diseases of the Colon & Rectum.